MTFP1 (Mitochondrial Fission Process 1) antibody is a tool used to study the MTFP1 protein, a key regulator of mitochondrial dynamics. MTFP1. also known as mitochondrial fission factor (MFF), is located on the mitochondrial outer membrane and plays a critical role in recruiting the GTPase DRP1 (Dynamin-related protein 1) to drive mitochondrial fission. Dysregulation of MTFP1 is linked to impaired mitochondrial fragmentation, affecting cellular energy metabolism, apoptosis, and stress responses.
Research on MTFP1 spans areas like cancer, neurodegenerative diseases, and metabolic disorders. Overexpression of MTFP1 promotes excessive mitochondrial fragmentation, contributing to apoptosis in cancer cells, while its downregulation is associated with neurodegenerative conditions like Parkinson’s disease. The MTFP1 antibody is widely used in techniques such as Western blotting, immunofluorescence, and immunohistochemistry to detect protein expression levels, localization, and interactions in cell or tissue samples. Recent studies also explore its role in metabolic reprogramming and therapeutic resistance, making it a biomarker of interest in precision medicine. Commercial MTFP1 antibodies are typically validated for specificity across human, mouse, and rat models, supporting cross-species comparative studies. Ongoing research aims to clarify its regulatory mechanisms and potential as a therapeutic target in mitochondrial dysfunction-related pathologies.